Clindamycin and dentistry

British Dental Journal

Volumn 199, Issue 1, 2005, Pages 23-26

  Addy, L D ^a   Martin, M V ^b  

^a UNIVERSITY DENTAL HOSPITAL   (United Kingdom)

^b LIVERPOOL UNIVERSITY DENTAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CLINDAMYCIN;

ANTIBIOTIC PROPHYLAXIS; ARTICLE; CHEMICALLY INDUCED DISORDER; DENTAL CARE; HUMAN; PSEUDOMEMBRANOUS COLITIS;

ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; CLINDAMYCIN; DENTAL CARE; ENTEROCOLITIS, PSEUDOMEMBRANOUS; HUMANS;

EID: 22344453192     PISSN: 00070610     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bdj.4812535     Document Type: Article

References (73)

1. Dental Practitioner's Formulary 2002-2004 British National Formulary No 44. London: The Royal Pharmaceutical Society of Great Britain and the British Medical Society, 2002.
2. Littler W A. Clindamycin suspension and endocarditis prophylaxis. Br Dent J 2001; 190: 407.
3. Williams M. Clindamycin and dentists. Lancet 1990; 335: 787.
4. Rippon R. Clindamycin and dentists. Br Dent J 1990; 168: 348.
5. Palmer N, Martin M. An investigation of antibiotic prescribing by general dental practitioners: a pilot study. Prim Dent Care 1998; 5: 11-14.
6. Thomas D W, Satterthwaite J, Absi E G, Lewis M A, Shepherd J P. Antibiotic prescription for acute dental conditions in the primary care setting. Br Dent J 1996; 181: 401-404.
7. Bombassaro A M, Wetmore S J, John M A. Clostridium difficile colitis following antibiotic prophylaxis for dental procedures. J Can Dent Assoc 2001; 67: 20-22.
8. Sandor G K, Low D E, Judd P L, Davidson R J. Antimicrobial treatment options in the management of odontogenic infections. J Can Dent Assoc 1998; 64: 508-514.
9. Mangundjaja S, Hardjawinata K. Clindamycin versus ampicillin in the treatment of odontogenic infections. Clin Ther 1990; 12: 242-249.
10. von Konow L, Nord C E, Nordenram A. Anaerobic bacteria in dentoalveolar infections. Int J Oral Surg 1981; 10: 313-322.
11. Phillips L, Fernandes R, Warren C. In-vitro comparison of erythromycin, lincomycin, and clindamycin. Br Med J 1970; 2: 89-90.
12. Dhawan V K, Thadepalli H. Clindamycin: a review of fifteen years of experience. Rev Infect Dis 1982; 4: 1133-1153.
13. Steigbigel N. Macrolides and Clindamycin. In Mandell, Douglas and Bennett's Principles and Practice of Infectious Diseases. 4th ed. pp 366-382. New York: Churchill Livingstone, 1995.
14. Nicholas P, Meyers B R, Levy R N, Hirschman S Z. Concentration of clindamycin in human bone. Antimicrob Agents Chemother 1975; 8: 220-221.
15. Bystedt H, A D A, Dornbusch K, Nord C E. Concentrations of azidocillin, erythromycin, doxycycline and clindamycin in human mandibular bone. Int J Oral Surg 1978; 7: 442-449.
16. Kuriyama T, Karasawa T, Nakagawa K, Saiki Y, Yamamoto E, Nakamura S. Bacteriologic features and antimicrobial susceptibility in isolates from orofacial odontogenic infections. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000; 90: 600-608.
17. Brook I, Frazier E H, Gher M E. Aerobic and anaerobic microbiology of periapical abscess. Oral Microbiol Immunol 1991; 6: 123-125.
18. Lewis M A, MacFarlane T W, McGowan D A. Quantitative bacteriology of acute dento-alveolar abscesses. J Med Microbiol 1986; 21: 101-104.
19. th ed. p p 111-1126. New York: Churchill Livingtone, 1995.
20. Bignardi G E. Risk factors for Clostriddium difficile infection. J Hosp Infect 1998; 40: 1-15.
21. Zehnder D, Kunzi U P, Maibach R, Zoppi M, Halter F, Neftel K A, et al. Frequency of antibiotics-associated colitis in hospitalized patients in 1974-1991. In Bern/St. Gallen. Comprehensive hospital drug monitoring. Schweiz Med Wochenschr 1995; 125: 676-683.
22. Lusk R H, Fekety F R Jr, Silva J Jr, Bodendorfer T, Devine B J, Kawanishi H, et al. Gastrointestinal side effects of clindamycin and ampicillin therapy. J Infect Dis 1977; 135 Suppl: S111-119.
23. Gurwith M J, Rabin H R, Love K. Diarrhoea associated with clindamycin and ampicillin therapy: preliminary results of a cooperative study. J Infect Dis 1977; 135 Suppl: S104-110.
24. Borriello S P, Larson H E. Antibiotic and pseudomembranous colitis. J Antimicrob Chemother 1981; 7 Suppl A: 53-65.
25. Schuen N J, Panzer J D, Atkinson W H. A comparison of clindamycin and penicillin Vin the treatment of oral infections. J Oral Surg 1974; 32: 503-505.
26. De Marco T J, Kluth E V. The use of cleocin in post-surgical periodontal patients. J Periodontol 1972; 43: 381-385.
27. Gilmore W C, Jacobus N V, Gorbach S L, Doku H C, Tally F P. A prospective double-blind evaluation of penicillin versus clindamycin in the treatment of odontogenic infections. J Oral Maxillofac Surg 1988; 46: 1065-1070.
28. Gordon J, Walker C, Lamster I, West T, Socransky S, Seiger M, et al. Efficacy of clindamycin hydrochloride in refractory periodontitis. 12-month results. J Periodontol 1985; 56(11 Suppl): 75-80.
29. C Scully, R Cawson. Medical Problems in Dentistry. 3rd ed. Oxford: Wright, 1993.
30. Raab W. Acute side effects of erythromycin, lincomycin and clindamycin. Int J Clin Pharmacol Biopharm 1977; 15: 90-97.
31. Lochmann O, Kohout P, Vymola F. Anaphylactic shock following the ad ministration of clindamycin. J Hyg Epidemiol Microbiol Immunol 1977; 21: 441-447.
32. Al Ahdal O, Bevan D R. Clindamycin-induced neuromuscular blockade. Can J Anaesth 1995; 42: 614-617.
33. Becker L D, Miller R D. Clindamycin enhances a nondepolarizing neuromuscular blockade. Anesthesiology 1976; 45: 84-87.
34. Compendium of Data Sheets and Summaries of Product Characteristics 1999-2000. London: Datapharm Publications Limited, 1999.
35. Shanson D C, Akash S, Harris M, Tadayon M. Erythromycin stearate, 1.5 g, for the oral prophylaxis of streptococcal bacteraemia in patients undergoing dental extraction: efficacy and tolerance. J Antimicrob Chemother 1985; 15: 83-90.
36. Shanson D C, Cannon P, Wilks M. Amoxycillin compared with penicillin V for the prophylaxis of dental bacteraemia. J Antimicrob Chemother 1978; 4: 431-436.
37. Sefton A M, Maskell J P, Kerawala C, Cannell H, Seymour A, Sun ZM, et al. Comparative efficacy and tolerance of erythromycin and josamycin in the prevention of bacteraemia following dental extraction. J Antimicrob Chemother 1990; 25: 975-984.
38. Eng R H, Wolff M, Smith S M. Failure of erythromycin in preventing bacterial endocarditis. Arch Intern Med 1982; 142: 1958-1959.
39. Durack D T, Petersdorf R G. Chemotherapy of experimental streptococcal endocarditis. I. Comparison of commonly recommended prophylactic regimens. J Clin Invest 1973; 52: 592-598.
40. Palmer N A, Pealing R, Ireland R S, Martin M V. A study of prophylactic antibiotic prescribing in National Health Service general dental practice in England. Br Dent J 2000; 189: 43-46.
41. Glauser M P, Francioli P. Successful prophylaxis against experimental streptococcal endocarditis with bacteriostatic antibiotics. J Infect Dis 1982; 146: 806-810.
42. Vermot D, Entenza J M, Vouillamoz J, Glauser M P, Moreillon P. Efficacy of clarithromycin versus that of clindamycin for single-dose prophylaxis of experimental streptococcal endocarditis. Antimicrob Agents Chemother 1996; 40: 809-811.
43. Dajani A S, Taubert K A, Wilson W, Bolger A F, Bayer A, Ferrieri P, et al. Prevention of bacterial endocarditis: recommendations by the American Heart Association. Clin Infect Dis 1997; 25: 1448-1458.
44. Sigusch B, Beier M, Klinger G, Pfister W, Glockmann E. A 2-step non-surgical procedure and systemic antibiotics in the treatment of rapidly progressive periodontitis. J Periodontol 2001; 72: 275-283.
45. Gordon J, Walker C, Hovliaras C, Socransky S. Efficacy of clindamycin hydrochloride in refractory periodontitis: 24-month results. J Periodontol 1990; 61: 686-691.
46. Magnusson I, Low S B, McArthur W P, Marks R G, Walker C B, Maruniak J, et al. Treatment of subjects with refractory periodontal disease. J Clin Periodontol 1994; 21: 628-637.
47. Walker C B, Gordon J M, Socransky S S. Antibiotic susceptibility testing of subgingival plaque samples. J Clin Periodontol 1983; 10: 422-432.
48. Walker C, Gordon J. The effect of clindamycin on the microbiota associated with refractory periodontitis. J Periodontol 1990; 61: 692-698.
49. Herrera D, Sanz M, Jepsen S, Needleman I, Roldan S. A systematic review on the effect of systemic antimicrobials as an adjunct to scaling and root planing in periodontitis patients. J Clin Periodontol 2002; 29(Suppl 3): 136-159.
50. Longman L P, Preston A J, Martin M V, Wilson N H. Endodontics in the adult patient: the role of antibiotics. J Dent 2000; 28: 539-548
51. Wasfy M O, McMahon K T, Minah G E, Falkler W A Jr. Microbiological evaluation of periapical infections in Egypt. Oral Microbiol Immunol 1992; 7: 100-105.
52. Sundqvist G. Associations between microbial species in dental root canal infections. Oral Microbiol Immunol 1992; 7: 257-262.
53. Molander A, Reit C, Dahlen G, Kvist T. Microbiological status of root-filled teeth with apical periodontitis. Int Endod J 1998; 31: 1-7.
54. Sundqvist G, Figdor D, Persson S, Sjogren U. Microbiologic analysis of teeth with failed endodontic treatment and the outcome of conservative re-treatment. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998; 85: 86-93.
55. Peciuliene V, Reynaud A H, Balciuniene I, Haapasalo M. Isolation of yeasts and enteric bacteria in root-filled teeth with chronic apical periodontitis. Int Endod J 2001; 34: 429-434.
56. Peciuliene V, Balciuniene I, Eriksen H M, Haapasalo M. Isolation of Enterococcus faecalis in previously root-filled canals in a Lithuanian population. J Endod 2000; 26: 593-595.
57. Dahlen G, Samuelsson W, Molander A, Reit C. Identification and antimicrobial susceptibility of enterococci isolated from the root canal. Oral Microbiol Immunol 2000; 15: 309-312.
58. Heintz C E, Deblinger R, Oliet S. Antibiotic sensitivities of enterococci isolated from treated root canals. J Endod 1975; 1: 373-376.
59. Gilad J Z, Teles R, Goodson M, White R R, Stashenko P. Development of a clindamycin-impregnated fiber as an intracanal medication in endodontic therapy. J Endod 1999; 25: 722-727.
60. Molander A, Reit C, Dahlen G. Microbiological evaluation of clindamycin as a root canal dressing in teeth with apical periodontitis. Int Endod J 1990; 23: 113-118.
61. Bystedt H, Nord C E, Nordenram A. Effect of azidocillin, erythromycin, clindamycin and doxycycline on postoperative complications after surgical removal of impacted mandibular third molars. Int J Oral Surg 1980; 9: 157-165.
62. Laird W R, Stenhouse D, Macfarlane T W. Control of post-operative infection. A comparative evaluation of clindamycin and phenoxymethylpenicillin. Br Dent J 1972; 133: 106-109.
63. Abu-Mowais M, Abdul-Amire R, El-Mosteky M. The clinical safety and efficacy of antibiotic prophylaxis after surgical removal of third molars. J Kuwait Med Assoc 1990; 24: 57-59.
64. Longman L P, Martin M V. The use of antibiotics in the prevention of post operative infection: a re-appraisal. Br Dent J 1991; 170: 257-262
65. Lewis M A, Meechan C, MacFarlane T W, Lamey P J, Kay E. Presentation and antimicrobial treatment of acute orofacial infections in general dental practice. Br Dent J 1989; 166: 41-45.
66. Gill Y, Scully C. Orofacial odontogenic infections: review of microbiology and current treatment. Oral Surg Oral Med Oral Pathol 1990; 70: 155-158.
67. Heimdahl A, Nord C E. Treatment of orofacial infections of odontogenic origin. Scand J Infect Dis Suppl 1985; 46: 101-105.
68. Kuriyama T, Nakagawa K, Karasawa T, Saiki Y, Yamamoto E, Nakamura S. Past administration of beta-lactam antibiotics and increase in the emergence of beta-lactamase-producing bacteria in patients with orofacial odontogenic infections. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000; 89: 186-192.
69. Baker K A, Fotos P G. The management of odontogenic infections. A rationale for appropriate chemotherapy. Dent Clin North Am 1994; 38: 689-706.
70. Heimdahl A, von Konow L, Satoh T, Nord C E. Clinical appearance of orofacial infections of odontogenic origin in relation to microbiological findings. J Clin Microbiol 1985; 22: 299-302.
71. Peterson L. Microbiology of Head and Neck Infections. Philadelphia: WB Saunders, 1991.
72. Finegold S M, Jousimies-Somer H. Recently described clinically important anaerobic bacteria: medical aspects. Clin Infect Dis 1997; 25 Suppl 2: S88-93.
73. Kannangara D W, Thadepalli H, McQuirter J L Bacteriology and treatment of dental infections. Oral Surg Oral Med Oral Pathol 1980; 50: 103-109.